Skip to main content
logo
Kazia Therapeutics logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.40
+0.61 (8.98%)
At close: Oct 15, 2026, 4:00 PM EDT
8.00
+0.60 (8.11%)
After-hours: Oct 15, 2026, 7:53 PM EDT

Kazia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
101772658128
Market Cap Growth
1232.10%2.91%-74.25%-54.61%-54.40%298.54%
Enterprise Value
55552447113
Last Close Price
7.406.2711.4358.00210.00493.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
80.075.854.1139743.178458.3411.23
PB Ratio
2.71-1.29-1.023.304.634.50
P/TBV Ratio
3.35----10.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
43.544.342.8035823.576855.409.91

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.00-0.05-0.060.150.10-
Net Debt / Equity Ratio
-1.490.480.10-0.29-0.30-0.73
Net Debt / EBITDA Ratio
3.890.300.040.160.245.40
Net Debt / FCF Ratio
4.820.300.110.230.243.03
Asset Turnover
0.040.130.10000.37
Quick Ratio
2.860.320.070.711.103.32
Current Ratio
2.870.350.241.421.403.53
Return on Equity (ROE)
-106.90%--2634.33%-134.97%-89.14%-32.41%
Return on Assets (ROA)
-25.70%-64.28%-71.63%-47.18%-33.76%-9.83%
Return on Capital Employed (ROCE)
-39.20%177.90%675.70%-117.70%-87.00%-12.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-15.00%-193.64%-262.32%-51.49%-29.57%-4.94%
FCF Yield
-9.86%-124.20%-93.86%-38.14%-26.91%-5.34%
Buyback Yield / Dilution
-213.01%-107.81%-43.08%-39.12%-12.57%-61.08%
SEC Filings: 10-K · 10-Q